American Cancer Society (2006) Cancer facts and figures 2006. American Cancer Society, Atlanta, GA
Google Scholar
Jaffer AK (2005) Issues in anticoagulant therapy: recent trials start to answer the tough questions. Cleve Clin J Med 72:157–163
PubMed
Article
Google Scholar
Otten HM, Mathijssen J, ten Cate H, Soesan M, Inghels M, Richel DJ, Prins MH (2004) Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon. Arch Intern Med 164:190–194
PubMed
Article
Google Scholar
Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343:1846–1850
PubMed
Article
CAS
Google Scholar
Schafer AI, Levine MN, Konkle BA, Kearon C (2003) Thrombotic disorders: diagnosis and treatment. Hematol Am Soc Hematol Educ Program 1:520–539
Google Scholar
Van Gerpen R, Mast ME (2004) Thromboembolic disorders in cancer. Clin J Oncol Nurs 8:289–299
PubMed
Article
Google Scholar
Kim SH, Brennan MF, Russo P, Burt ME, Coit DG (1998) The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer 82:389–394
PubMed
Article
CAS
Google Scholar
Lee JJ, Kupfer J, Raissi S, Geller SA, Siegel RJ (1998) Rapid extension of left adrenocortical carcinoma into the right atrium. J Am Soc Echocardiogr 11:86–88
PubMed
Article
CAS
Google Scholar
Zisman A, Wieder JA, Pantuck AJ, Chao DH, Dorey F, Said JW, Gitlitz BJ, deKernion JB, Figlin RA, Belldegrun AS (2003) Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. J Urol 169:909–916
PubMed
Article
Google Scholar
Lanciego C, Chacon JL, Julian A, Andrade J, Lopez L, Martinez B, Cruz M, Garcia-Garcia L (2001) Stenting as first option for endovascular treatment of malignant superior vena cava syndrome. AJR 177:585–593
PubMed
CAS
Google Scholar
Marcy PY, Magne N, Bentolila F, Drouillard J, Bruneton JN, Descamps B (2001) Superior vena cava obstruction: Is stenting necessary? Support Care Cancer 9:103–107
PubMed
Article
CAS
Google Scholar
Trousseau A (1865) Phlegmasia alba dolens. In: Trousseau A (ed) Clinique medicale de l’Hotel-Dieu de Paris, Vol. 3. Balliere, Paris, pp 654–712
Saphner T, Tormey DC, Gray R (1991) Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol 9:286–294
PubMed
CAS
Google Scholar
Viale PH, Schwartz RN (2004) Venous thromboembolism in patients with cancer. Part II. Current treatment strategies. Clin J Oncol Nurs 8:465–469
PubMed
Article
Google Scholar
Cunningham RS (2005) Therapeutic options for the treatment of cancer-associated thrombosis. Semin Oncol Nurs 21(Suppl 1):21–40
PubMed
Article
Google Scholar
Rickles FR, Edwards RL (1983) Activation of blood coagulation in cancer: Trousseau’s syndrome revisited. Blood 62:14–31
PubMed
CAS
Google Scholar
Levitan N., Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R, Rimm AA (1999) Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 78:285–291
Article
CAS
Google Scholar
Kuzel T, Esparaz B, Green D, Kies M (1990) Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin. Cancer 65:885–889
PubMed
Article
CAS
Google Scholar
Feffer SE, Carmosino LS, Fox RL (1989) Acquired protein C deficiency in patients with breast cancer receiving cyclophosphamide, methotrexate, and 5-fluorouracil. Cancer 63:1303–1307
PubMed
Article
CAS
Google Scholar
Bertomeu MC, Gallo S, Lauri D, Levine MN, Orr FW, Buchanan MR (1990) Chemotherapy enhances endothelial cell reactivity to platelets. Clin Exp Metastasis 8:511–518
PubMed
Article
CAS
Google Scholar
Rodrigues CI, Njo KH, Karim AB (1993) Hypofractionated radiation therapy in the treatment of superior vena cava syndrome. Lung Cancer 10:221–228
PubMed
Article
CAS
Google Scholar
Charnsangavej C, Carrasco CH, Wallace S, Wright KC, Ogawa K, Richli W, Gianturco C (1986) Stenosis of the vena cava: preliminary assessment of treatment with expandable metallic stents. Radiology 161:295–298
PubMed
CAS
Google Scholar
Uberoi R (2006) Quality assurance guidelines for superior vena cava stenting in malignant disease. Cardiovasc Interv Radiol 29:319–322
Article
Google Scholar
Wallace MJ, Jean JL, Gupta S, Eapen GA, Johnson MM, Ahrar K, Madoff DC, Morello FA, Murthy R, Hicks ME (2004) Use of inferior vena caval filters and survival in patients with malignancy. Cancer 101:1902–1907
PubMed
Article
Google Scholar
Jarrett BP, Dougherty MJ, Calligaro KD (2002) Inferior vena cava filters in malignant disease. J Vasc Surg 36:704–707
PubMed
Google Scholar
Henkle G, Kunz P, Funaki B (2004) Patterns of referral for inferior vena caval filtration: delays and their impact. AJR 183:1021–1024
PubMed
Google Scholar
Decousus H, Leizorovicz A, Parent F, et al. (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with deep venous thrombosis prevention du risque d’embolie pulmonaire par interruption. Cave Study Group. N Engl J Med 338:409–415
PubMed
Article
CAS
Google Scholar
Hann CL, Streiff MB (2005) The role of vena caval filters in the management of venous thromboembolism. Blood Rev 19:179–202
PubMed
Article
Google Scholar